Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Ghent
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).
Age
18–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with persistent asthma
Asthma treatment for at least 12 months
Regular visitors of the participating community pharmacy
You may not be if
Severe co-morbidity
\> 10 pack-years smoking history
Asthma Control Test score \< 15 or =25
Clareo Health | Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study
